Histologic Assessment of a Fast-Set Mineral Trioxide Aggregate (MTA) and Two Novel Antibacterial-Enhanced Fast-Set MTAs for Apexification and Periapical Healing of Teeth With Incomplete Root Formation in a Rat Model: An In Vivo Animal Study

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 4; p. e59064
• Main Authors: Fathima, Ayesha, Ravindran, Vignesh, Jeevanandan, Ganesh, Mohanraj, Karthik Ganesh, Eswaramoorthy, Rajalakshmanan, Arthanari, Abirami
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 26.04.2024; Cureus
• Subjects: Antibiotics; Antimicrobial agents; Biocompatibility; Cement; Cytotoxicity; Dentistry; Fluorides; Hydration; Pain management; Pediatrics; Public Health; Teeth; Zirconium; Zirconium oxides; Brazil; Japan; metronidazole; calcium fluoride; doxycycline; calcific barrier; cytotoxicity
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.59064

Background Pulp necrosis in incomplete root formation halts dentine development, resulting in larger canals with fragile walls and an open apex, complicating canal instrumentation and apical stop formation. Bioactive endodontic cements such as mineral trioxide aggregate (MTA) are crucial for creating artificial apical barriers or inducing apical foramen closure, but challenges remain regarding their antimicrobial efficacy and cytotoxicity. Modifications to MTA formulations aim to address these concerns. Methods This in vivo animal study involved 80 Wistar albino rats, with incomplete root formation induced by pulp exposure. Rats were divided into four groups receiving different MTA formulations for apexification: conventional MTA, modified MTA, and MTA enhanced with metronidazole or doxycycline. Histopathological evaluations were conducted at seven and 28 days post-treatment to assess calcific barrier formation, inflammatory reactions, and antimicrobial efficacy. Results By day 7, modified MTA formulations exhibited enhanced antibacterial activity compared to conventional MTA (p = 0.000), with fewer inflammatory reactions and microorganisms. By day 28, modified formulations showed superior calcific barrier formation, particularly in the metronidazole- and doxycycline-enhanced groups compared to conventional MTA (p = 0.000). These outcomes suggest that modifications to MTA formulations improve antimicrobial efficacy and calcific barrier formation in vivo. Conclusion Novel modified MTA formulations, particularly those enhanced with metronidazole or doxycycline, exhibit superior antibacterial efficacy and calcific barrier formation compared to conventional MTA. Further long-term studies are warranted to validate these findings for potential clinical translation.